Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Flow Cytometry Buffer Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Flow Cytometry Buffer Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 151 Pages
Report ld: 5344092
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Flow Cytometry Buffer market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
The Flow Cytometry Buffer market is driven by several factors that contribute to the adoption and growth of these specialized solutions in flow cytometry applications. Some key drivers include:
Sample Preservation: Flow cytometry buffers are formulated to maintain the viability and integrity of cells or particles during the staining and analysis process. Proper buffer selection helps preserve the characteristics of the sample for accurate analysis.
Cell Stabilization: Buffers are used to stabilize cells and prevent clumping or aggregation, ensuring uniform dispersion and accurate analysis in flow cytometry experiments.
Cell Permeabilization: Some flow cytometry assays require cell permeabilization to allow fluorescent probes to access intracellular targets. Specialized permeabilization buffers enable the penetration of dyes into cells without compromising their structural integrity.
Antibody Binding: Buffers are designed to optimize the binding of fluorescently labeled antibodies to target cells, enabling precise identification and analysis of specific cell populations.
Blocking Unspecific Binding: Flow cytometry buffers can include blocking agents that prevent nonspecific binding of antibodies and reagents to cells, reducing background noise and improving data accuracy.
Buffer pH and Ionic Strength: Proper pH and ionic strength are crucial for maintaining cellular structure and the performance of fluorescent dyes. Buffers help maintain the physiological conditions required for accurate analysis.
Instrument Compatibility: Manufacturers develop flow cytometry buffers that are optimized for specific flow cytometry instruments, ensuring compatibility and reliable results.
Multiparametric Analysis: Buffers enable the simultaneous analysis of multiple parameters, such as cell size, granularity, and fluorescence intensity, allowing researchers to gather comprehensive data from single-cell analysis.
Standardization: Flow cytometry buffers are formulated following established protocols and quality control measures, ensuring consistent and reproducible results across different experiments and labs.
Rising Research and Clinical Applications: Flow cytometry is widely used in both research and clinical settings for cell analysis, diagnosis, and monitoring. The increasing adoption of flow cytometry across various disciplines drives the demand for specialized buffers.
Advancements in Antibody Labeling: As fluorescent labeling techniques improve, the need for compatible buffers that maximize antibody binding and fluorescent signal detection also grows.
Drug Discovery and Development: Flow cytometry plays a crucial role in drug discovery, target identification, and toxicity testing. Buffers ensure accurate analysis of cell responses to compounds and drugs.
Immunology and Cancer Research: Flow cytometry is pivotal in immunology and cancer research for analyzing immune cell subsets and detecting specific markers. Buffers are essential to obtain reliable data in these studies.
Diagnostic Applications: Flow cytometry is used for clinical diagnostics, including immunophenotyping and monitoring disease progression. Accurate analysis depends on suitable buffers.
Technological Advancements: Ongoing advancements in flow cytometry instrumentation and fluorescent dyes drive the need for buffers optimized for new technologies and applications.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Flow Cytometry Buffer market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Thermo Fisher
- Agilent Technologies
- Sartorius AG
- BD
- Merck Millipore
- Beckman Coulter
- Siemens Healthcare
- Sysmex
- BioLegend
- Miltenyi Biotec
- Tonbo Biosciences
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Surface Staining Buffer
- Fixation Buffer
- Viability Staining Buffer
- Others
Segment by Application
- Academic and Research Institutes
- Hospitals and Clinical Testing Laboratories
- Pharmaceutical and Biotechnology Companies
CHAPTER OUTLINE
Chapter 1: Defines the Flow Cytometry Buffer study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Flow Cytometry Buffer: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Flow Cytometry Buffer Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Surface Staining Buffer
1.2.3 Fixation Buffer
1.2.4 Viability Staining Buffer
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Flow Cytometry Buffer Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic and Research Institutes
1.3.3 Hospitals and Clinical Testing Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Flow Cytometry Buffer Revenue Estimates and Forecasts 2020-2031
2.2 Global Flow Cytometry Buffer Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Flow Cytometry Buffer Sales Estimates and Forecasts 2020-2031
2.4 Global Flow Cytometry Buffer Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Flow Cytometry Buffer Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Flow Cytometry Buffer Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Surface Staining Buffer Market Size by Manufacturers
3.5.2 Fixation Buffer Market Size by Manufacturers
3.5.3 Viability Staining Buffer Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Flow Cytometry Buffer Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Flow Cytometry Buffer Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Flow Cytometry Buffer Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Flow Cytometry Buffer Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Flow Cytometry Buffer Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Flow Cytometry Buffer Sales and Revenue by Type (2020-2031)
6.4 North America Flow Cytometry Buffer Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Flow Cytometry Buffer Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Flow Cytometry Buffer Sales and Revenue by Type (2020-2031)
7.4 Europe Flow Cytometry Buffer Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Flow Cytometry Buffer Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Flow Cytometry Buffer Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Flow Cytometry Buffer Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Flow Cytometry Buffer Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Flow Cytometry Buffer Sales and Revenue by Type (2020-2031)
9.4 Central and South America Flow Cytometry Buffer Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Flow Cytometry Buffer Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Flow Cytometry Buffer Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Flow Cytometry Buffer Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Flow Cytometry Buffer Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher
11.1.1 Thermo Fisher Corporation Information
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Flow Cytometry Buffer Sales by Product in 2024
11.1.6 Thermo Fisher Flow Cytometry Buffer Sales by Application in 2024
11.1.7 Thermo Fisher Flow Cytometry Buffer Sales by Geographic Area in 2024
11.1.8 Thermo Fisher Flow Cytometry Buffer SWOT Analysis
11.1.9 Thermo Fisher Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Corporation Information
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.2.4 Agilent Technologies Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Agilent Technologies Flow Cytometry Buffer Sales by Product in 2024
11.2.6 Agilent Technologies Flow Cytometry Buffer Sales by Application in 2024
11.2.7 Agilent Technologies Flow Cytometry Buffer Sales by Geographic Area in 2024
11.2.8 Agilent Technologies Flow Cytometry Buffer SWOT Analysis
11.2.9 Agilent Technologies Recent Developments
11.3 Sartorius AG
11.3.1 Sartorius AG Corporation Information
11.3.2 Sartorius AG Business Overview
11.3.3 Sartorius AG Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.3.4 Sartorius AG Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Sartorius AG Flow Cytometry Buffer Sales by Product in 2024
11.3.6 Sartorius AG Flow Cytometry Buffer Sales by Application in 2024
11.3.7 Sartorius AG Flow Cytometry Buffer Sales by Geographic Area in 2024
11.3.8 Sartorius AG Flow Cytometry Buffer SWOT Analysis
11.3.9 Sartorius AG Recent Developments
11.4 BD
11.4.1 BD Corporation Information
11.4.2 BD Business Overview
11.4.3 BD Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.4.4 BD Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 BD Flow Cytometry Buffer Sales by Product in 2024
11.4.6 BD Flow Cytometry Buffer Sales by Application in 2024
11.4.7 BD Flow Cytometry Buffer Sales by Geographic Area in 2024
11.4.8 BD Flow Cytometry Buffer SWOT Analysis
11.4.9 BD Recent Developments
11.5 Merck Millipore
11.5.1 Merck Millipore Corporation Information
11.5.2 Merck Millipore Business Overview
11.5.3 Merck Millipore Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.5.4 Merck Millipore Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Merck Millipore Flow Cytometry Buffer Sales by Product in 2024
11.5.6 Merck Millipore Flow Cytometry Buffer Sales by Application in 2024
11.5.7 Merck Millipore Flow Cytometry Buffer Sales by Geographic Area in 2024
11.5.8 Merck Millipore Flow Cytometry Buffer SWOT Analysis
11.5.9 Merck Millipore Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Corporation Information
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.6.4 Beckman Coulter Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Beckman Coulter Recent Developments
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Corporation Information
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.7.4 Siemens Healthcare Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Siemens Healthcare Recent Developments
11.8 Sysmex
11.8.1 Sysmex Corporation Information
11.8.2 Sysmex Business Overview
11.8.3 Sysmex Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.8.4 Sysmex Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Sysmex Recent Developments
11.9 BioLegend
11.9.1 BioLegend Corporation Information
11.9.2 BioLegend Business Overview
11.9.3 BioLegend Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.9.4 BioLegend Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 BioLegend Recent Developments
11.10 Miltenyi Biotec
11.10.1 Miltenyi Biotec Corporation Information
11.10.2 Miltenyi Biotec Business Overview
11.10.3 Miltenyi Biotec Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.10.4 Miltenyi Biotec Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Miltenyi Biotec Recent Developments
11.11 Tonbo Biosciences
11.11.1 Tonbo Biosciences Corporation Information
11.11.2 Tonbo Biosciences Business Overview
11.11.3 Tonbo Biosciences Flow Cytometry Buffer Product Models, Descriptions and Specifications
11.11.4 Tonbo Biosciences Flow Cytometry Buffer Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Tonbo Biosciences Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Flow Cytometry Buffer Industry Chain
12.2 Flow Cytometry Buffer Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Flow Cytometry Buffer Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Flow Cytometry Buffer Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Flow Cytometry Buffer Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Flow Cytometry Buffer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Flow Cytometry Buffer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Flow Cytometry Buffer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Flow Cytometry Buffer Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Flow Cytometry Buffer Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Flow Cytometry Buffer Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (L)
Table 7. Global Flow Cytometry Buffer Sales by Region (2020-2025) & (L)
Table 8. Global Flow Cytometry Buffer Sales by Region (2026-2031) & (L)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Flow Cytometry Buffer Sales by Manufacturers (2020-2025) & (L)
Table 11. Global Flow Cytometry Buffer Sales Share by Manufacturers (2020-2025)
Table 12. Global Flow Cytometry Buffer Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Flow Cytometry Buffer Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Flow Cytometry Buffer by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry Buffer as of 2024)
Table 16. Global Flow Cytometry Buffer Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Flow Cytometry Buffer Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/L)
Table 18. Key Manufacturers Flow Cytometry Buffer Manufacturing Base and Headquarters
Table 19. Global Flow Cytometry Buffer Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Flow Cytometry Buffer Sales by Type (2020-2025) & (L)
Table 23. Global Flow Cytometry Buffer Sales by Type (2026-2031) & (L)
Table 24. Global Flow Cytometry Buffer Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Flow Cytometry Buffer Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Flow Cytometry Buffer ASP by Type (2020-2031) & (US$/L)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Flow Cytometry Buffer Sales by Application (2020-2025) & (L)
Table 29. Global Flow Cytometry Buffer Sales by Application (2026-2031) & (L)
Table 30. Flow Cytometry Buffer High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Flow Cytometry Buffer Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Flow Cytometry Buffer Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Flow Cytometry Buffer ASP by Application (2020-2031) & (US$/L)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Flow Cytometry Buffer Growth Accelerators and Market Barriers
Table 37. North America Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Flow Cytometry Buffer Sales (L) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Flow Cytometry Buffer Growth Accelerators and Market Barriers
Table 40. Europe Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Flow Cytometry Buffer Sales (L) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Flow Cytometry Buffer Sales (L) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Flow Cytometry Buffer Growth Accelerators and Market Barriers
Table 45. Southeast Asia Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Flow Cytometry Buffer Investment Opportunities and Key Challenges
Table 47. Central and South America Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Flow Cytometry Buffer Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Flow Cytometry Buffer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Corporation Information
Table 51. Thermo Fisher Description and Major Businesses
Table 52. Thermo Fisher Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher Flow Cytometry Buffer SWOT Analysis
Table 58. Thermo Fisher Recent Developments
Table 59. Agilent Technologies Corporation Information
Table 60. Agilent Technologies Description and Major Businesses
Table 61. Agilent Technologies Product Models, Descriptions and Specifications
Table 62. Agilent Technologies Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 63. Agilent Technologies Sales Value Proportion by Product in 2024
Table 64. Agilent Technologies Sales Value Proportion by Application in 2024
Table 65. Agilent Technologies Sales Value Proportion by Geographic Area in 2024
Table 66. Agilent Technologies Flow Cytometry Buffer SWOT Analysis
Table 67. Agilent Technologies Recent Developments
Table 68. Sartorius AG Corporation Information
Table 69. Sartorius AG Description and Major Businesses
Table 70. Sartorius AG Product Models, Descriptions and Specifications
Table 71. Sartorius AG Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 72. Sartorius AG Sales Value Proportion by Product in 2024
Table 73. Sartorius AG Sales Value Proportion by Application in 2024
Table 74. Sartorius AG Sales Value Proportion by Geographic Area in 2024
Table 75. Sartorius AG Flow Cytometry Buffer SWOT Analysis
Table 76. Sartorius AG Recent Developments
Table 77. BD Corporation Information
Table 78. BD Description and Major Businesses
Table 79. BD Product Models, Descriptions and Specifications
Table 80. BD Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 81. BD Sales Value Proportion by Product in 2024
Table 82. BD Sales Value Proportion by Application in 2024
Table 83. BD Sales Value Proportion by Geographic Area in 2024
Table 84. BD Flow Cytometry Buffer SWOT Analysis
Table 85. BD Recent Developments
Table 86. Merck Millipore Corporation Information
Table 87. Merck Millipore Description and Major Businesses
Table 88. Merck Millipore Product Models, Descriptions and Specifications
Table 89. Merck Millipore Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 90. Merck Millipore Sales Value Proportion by Product in 2024
Table 91. Merck Millipore Sales Value Proportion by Application in 2024
Table 92. Merck Millipore Sales Value Proportion by Geographic Area in 2024
Table 93. Merck Millipore Flow Cytometry Buffer SWOT Analysis
Table 94. Merck Millipore Recent Developments
Table 95. Beckman Coulter Corporation Information
Table 96. Beckman Coulter Description and Major Businesses
Table 97. Beckman Coulter Product Models, Descriptions and Specifications
Table 98. Beckman Coulter Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 99. Beckman Coulter Recent Developments
Table 100. Siemens Healthcare Corporation Information
Table 101. Siemens Healthcare Description and Major Businesses
Table 102. Siemens Healthcare Product Models, Descriptions and Specifications
Table 103. Siemens Healthcare Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 104. Siemens Healthcare Recent Developments
Table 105. Sysmex Corporation Information
Table 106. Sysmex Description and Major Businesses
Table 107. Sysmex Product Models, Descriptions and Specifications
Table 108. Sysmex Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 109. Sysmex Recent Developments
Table 110. BioLegend Corporation Information
Table 111. BioLegend Description and Major Businesses
Table 112. BioLegend Product Models, Descriptions and Specifications
Table 113. BioLegend Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 114. BioLegend Recent Developments
Table 115. Miltenyi Biotec Corporation Information
Table 116. Miltenyi Biotec Description and Major Businesses
Table 117. Miltenyi Biotec Product Models, Descriptions and Specifications
Table 118. Miltenyi Biotec Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 119. Miltenyi Biotec Recent Developments
Table 120. Tonbo Biosciences Corporation Information
Table 121. Tonbo Biosciences Description and Major Businesses
Table 122. Tonbo Biosciences Product Models, Descriptions and Specifications
Table 123. Tonbo Biosciences Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 124. Tonbo Biosciences Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Flow Cytometry Buffer Product Picture
Figure 2. Global Flow Cytometry Buffer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Surface Staining Buffer Product Picture
Figure 4. Fixation Buffer Product Picture
Figure 5. Viability Staining Buffer Product Picture
Figure 6. Others Product Picture
Figure 7. Global Flow Cytometry Buffer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Academic and Research Institutes
Figure 9. Hospitals and Clinical Testing Laboratories
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Flow Cytometry Buffer Report Years Considered
Figure 12. Global Flow Cytometry Buffer Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 14. Global Flow Cytometry Buffer Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Flow Cytometry Buffer Revenue Market Share by Region (2020-2031)
Figure 16. Global Flow Cytometry Buffer Sales (2020-2031) & (L)
Figure 17. Global Flow Cytometry Buffer Sales (CAGR) by Region (2020-2031) (L)
Figure 18. Global Flow Cytometry Buffer Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Flow Cytometry Buffer Sales Volume Market Share in 2024
Figure 20. Global Flow Cytometry Buffer Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Surface Staining Buffer Revenue Market Share by Manufacturer in 2024
Figure 23. Fixation Buffer Revenue Market Share by Manufacturer in 2024
Figure 24. Viability Staining Buffer Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Flow Cytometry Buffer Sales Market Share by Type (2020-2031)
Figure 27. Global Flow Cytometry Buffer Revenue Market Share by Type (2020-2031)
Figure 28. Global Flow Cytometry Buffer Sales Market Share by Application (2020-2031)
Figure 29. Global Flow Cytometry Buffer Revenue Market Share by Application (2020-2031)
Figure 30. North America Flow Cytometry Buffer Sales YoY (2020-2031) & (L)
Figure 31. North America Flow Cytometry Buffer Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Flow Cytometry Buffer Sales Revenue (US$ Million) in 2024
Figure 33. North America Flow Cytometry Buffer Sales Volume (L) by Type (2020- 2031)
Figure 34. North America Flow Cytometry Buffer Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Flow Cytometry Buffer Sales Volume (L) by Application (2020-2031)
Figure 36. North America Flow Cytometry Buffer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Flow Cytometry Buffer Sales YoY (2020-2031) & (L)
Figure 41. Europe Flow Cytometry Buffer Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Flow Cytometry Buffer Sales Revenue (US$ Million) in 2024
Figure 43. Europe Flow Cytometry Buffer Sales Volume (L) by Type (2020-2031)
Figure 44. Europe Flow Cytometry Buffer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Flow Cytometry Buffer Sales Volume (L) by Application (2020-2031)
Figure 46. Europe Flow Cytometry Buffer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 48. France Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Flow Cytometry Buffer Sales YoY (2020-2031) & (L)
Figure 53. Asia-Pacific Flow Cytometry Buffer Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Flow Cytometry Buffer Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Flow Cytometry Buffer Sales Volume (L) by Type (2020- 2031)
Figure 56. Asia-Pacific Flow Cytometry Buffer Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Flow Cytometry Buffer Sales Volume (L) by Application (2020-2031)
Figure 58. Asia-Pacific Flow Cytometry Buffer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 63. India Flow Cytometry Buffer Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Flow Cytometry Buffer Sales YoY (2020-2031) & (L)
Figure 65. Central and South America Flow Cytometry Buffer Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Flow Cytometry Buffer Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Flow Cytometry Buffer Sales Volume (L) by Type (2021-2031)
Figure 68. Central and South America Flow Cytometry Buffer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Flow Cytometry Buffer Sales Volume (L) by Application (2020-2031)
Figure 70. Central and South America Flow Cytometry Buffer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Flow Cytometry Buffer Sales YoY (2020-2031) & (L)
Figure 74. Middle East and Africa Flow Cytometry Buffer Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Flow Cytometry Buffer Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Flow Cytometry Buffer Sales Volume (L) by Type (2021-2031)
Figure 77. South America Flow Cytometry Buffer Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Flow Cytometry Buffer Sales Volume (L) by Application (2020-2031)
Figure 79. Middle East and Africa Flow Cytometry Buffer Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Flow Cytometry Buffer Revenue (2020-2025) & (US$ Million)
Figure 84. Flow Cytometry Buffer Industry Chain Mapping
Figure 85. Regional Flow Cytometry Buffer Manufacturing Base Distribution (%)
Figure 86. Global Flow Cytometry Buffer Production Market Share by Region (2020-2031)
Figure 87. Flow Cytometry Buffer Production Process
Figure 88. Regional Flow Cytometry Buffer Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Flow Cytometry Buffer market?
The top companies in the global Flow Cytometry Buffer market are Thermo Fisher、Agilent Technologies、Sartorius AG.
Related Reports
Flow Cytometry Buffer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Flow Cytometry Buffer was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global Flow Cytometry Buffer Market Research Report 2026
The global Flow Cytometry Buffer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 118
USD 2900.00
(Single User License)
Global Flow Cytometry Buffer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Flow Cytometry Buffer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 99
USD 4250.00
(Single User License)
Flow Cytometry Buffer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Flow Cytometry Buffer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 119
USD 3950.00
(Single User License)
Global Flow Cytometry Buffer Market Research Report 2025
The global market for Flow Cytometry Buffer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 96
USD 2900.00
(Single User License)
Global Flow Cytometry Buffer Market Research Report 2024
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
Published Date: 2024-02-05
Pages: 92
USD 2900.00
(Single User License)
Flow Cytometry Buffer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
Published Date: 2024-01-10
Pages: 128
USD 3950.00
(Single User License)
Flow Cytometry Buffer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Flow Cytometry Buffer was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)Global Flow Cytometry Buffer Market Research Report 2026
The global Flow Cytometry Buffer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 118
USD 2900.00 (Single User License)Global Flow Cytometry Buffer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Flow Cytometry Buffer market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 99
USD 4250.00 (Single User License)Flow Cytometry Buffer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Flow Cytometry Buffer was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 119
USD 3950.00 (Single User License)Global Flow Cytometry Buffer Market Research Report 2025
The global market for Flow Cytometry Buffer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 96
USD 2900.00 (Single User License)Global Flow Cytometry Buffer Market Research Report 2024
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
Published: 2024-02-05
Pages: 92
USD 2900.00 (Single User License)Flow Cytometry Buffer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Flow Cytometry Buffer can be used for the immunofluorescent staining of single-cell suspensions prepared from either lymphoid tissues, bone marrow, peripheral blood, or cultured cells. Stain Buffer (FBS) is useful for the dilution and application of fluorescent reagents as well as for the suspension, washing, and storage of cells destined for flow cytometric analysis.
Published: 2024-01-10
Pages: 128
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now